Skip to main content

Advertisement

SpringerLink
Log in

Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders

  • Review Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

There have been several endeavors made to investigate the potential role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography (FDG-PET) (and tracers) and PET-computed tomography imaging in various benign disorders, particularly those related to thoracic structures. These various conditions can be broadly categorized into three groups: (a) infectious diseases (mycobacterial, fungal, bacterial infection), (b) active granulomatous disease such as sarcoidosis, and (c) other non-infectious/inflammatory conditions or proliferative disorders (e.g., radiation pneumonitis, post-lung transplant lymphoproliferative disorders, occupational pleuropulmonary complications, and post-surgical conditions), all of which can demonstrate varying degrees of FDG uptake on PET scans based upon the degree of inflammatory activity. This article reviews the current state of this very important application of FDG–PET imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Karam M, Roberts-Klein S, Shet N, Chang J, Feustel P (2008) Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology. J Nucl Med 49(9):1429–1436

    Article  PubMed  Google Scholar 

  2. Bataille L, Lonneux M, Weynand B, Schoonbroodt D, Collard P, Deprez PH (2008) EUS–FNA and FDG–PET are complementary procedures in the diagnosis of enlarged mediastinal lymph nodes. Acta Gastroenterol Belg 71(2):219–229

    PubMed  CAS  Google Scholar 

  3. Sochocky S (1958) Tuberculoma of the lung. Am Rev Tuberc 78(3):403–410

    PubMed  CAS  Google Scholar 

  4. Palmer PE (1979) Pulmonary tuberculosis—usual and unusual radiographic presentations. Semin Roentgenol 14(3):204–243

    Article  PubMed  CAS  Google Scholar 

  5. Braun JJ, Kessler R, Constantinesco A, Imperiale A (2008) (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 35(8):1537–1543, Epub 2008 Apr 17

    Article  PubMed  Google Scholar 

  6. Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211

    PubMed  CAS  Google Scholar 

  7. Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA (2007) Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 29(2):418–422

    Article  PubMed  CAS  Google Scholar 

  8. Hyodo E, Hozumi T, Takemoto Y et al (2004) Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 90:1275–1280

    Article  PubMed  CAS  Google Scholar 

  9. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M (2004) The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 94:99–103

    Article  PubMed  Google Scholar 

  10. Yamagishi H, Shirai N, Takagi M et al (2003) Identification of cardiac sarcoidosis with 13N–NH3/18F-FDG PET. J Nucl Med 44:1030–1036

    PubMed  Google Scholar 

  11. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M (2004) Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45(12):1989–1998

    PubMed  Google Scholar 

  12. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26(15):1538–1543, Epub 2005 Apr 4

    Article  PubMed  Google Scholar 

  13. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, Zhuang H (2002) Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32(4):293–321

    Article  PubMed  Google Scholar 

  14. Basu S, Alavi A (2007) Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. Clin Nucl Med 32(5):407–408

    Article  PubMed  Google Scholar 

  15. Basu S, Alzeair S, Li G, Dadparvar S, Alavi A (2007) Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease. Mol Imaging Biol 9(6):333–339

    Article  PubMed  Google Scholar 

  16. Shukuya T, Naka G, Kawana A, Sugiyama H, Kobayashi N, Kudo K, Yago Y, Tamegai Y, Kubota K (2006) Pneumoconiosis associated with an esophageal ulcer and uptake revealed in FDGPET. Intern Med 45(5):293–296, Epub 2006 Apr 3

    Article  PubMed  Google Scholar 

  17. Bandoh S, Fujita J, Yamamoto Y, Nishiyama Y, Ueda Y, Tojo Y, Ishii T, Kubo A, Ishida T (2003) A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography. Ann Nucl Med 17(7):597–600

    Article  PubMed  Google Scholar 

  18. Williams HT, Solis V, Dillard TA, Gossage JR Jr, Freant LJ (2008) Malignancy in kaolin pneumoconiosis found with F-18 FDG positron emission tomography. Clin Nucl Med 33(1):4–7

    Article  PubMed  Google Scholar 

  19. Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, Zhao S, Okamoto S, Tamaki N (2007) Comparison of MET–PET and FDG–PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 21(6):331–337, Epub 2007 Aug 27

    Article  PubMed  Google Scholar 

  20. O’Connell M, Kennedy M (2004) Progressive massive fibrosis secondary to pulmonary silicosis appearance on F-18 fluorodeoxyglucose PET/CT. Clin Nucl Med 29(11):754–755

    Article  PubMed  Google Scholar 

  21. Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC, Bonnaud F (2004) Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 24(5):814–821

    Article  PubMed  CAS  Google Scholar 

  22. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST (2002) Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 43(9):1144–1149

    PubMed  Google Scholar 

  23. Mavi A, Basu S, Cermik TF, Urhan M, Bathaii M, Thiruvenkatasamy D, Houseni M, Dadparvar S, Alavi A (2009) Potential of dual time point FDG–PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol 11(5):369–378

    Article  PubMed  Google Scholar 

  24. Marom EM, McAdams HP, Butnor KJ, Coleman RE (2004) Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG–PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. J Thorac Imaging 19(2):74–78

    Article  PubMed  Google Scholar 

  25. Bakheet SM, Powe J (1998) Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28:352–358

    Article  PubMed  CAS  Google Scholar 

  26. Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH (1999) A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr 171:49–53

    Article  CAS  Google Scholar 

  27. Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S et al (2003) Pulmonary paragonimiasis mimicking lung cancer on FDG–PET imaging. Anticancer Res 23:3437–3440

    PubMed  Google Scholar 

  28. Lin P, Chu J, Pocock N (2000) Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med 25:866–869

    Article  PubMed  CAS  Google Scholar 

  29. Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M et al (2001) FDG–PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 19:215–218

    PubMed  CAS  Google Scholar 

  30. Yun M, Yeh D, Araujo LI et al (2001) F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26(4):314–319

    Article  PubMed  CAS  Google Scholar 

  31. Yun M, Jang S, Cucchiara A et al (2002) 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32(1):70–76

    Article  PubMed  Google Scholar 

  32. Bural GG, Torigian DA, Chamroonrat W, Alkhawaldeh K, Houseni M, El-Haddad G, Alavi A (2006) Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG–PET and CT image analysis: a new concept. Nucl Med Biol 33(8):1037–1043, Epub 2006 Oct 4

    Article  PubMed  CAS  Google Scholar 

  33. Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A (2008) FDG–PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35(3):562–569

    Article  PubMed  Google Scholar 

  34. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU (2005) The value of [18F]FDG–PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674–681

    Article  PubMed  Google Scholar 

  35. Blockmans D, De CL, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137

    Article  PubMed  Google Scholar 

  36. Hautzel H, Sander O, Heinzel A, Schneider M, Müller HW (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49(7):1107–1113, Epub 2008 Jun 13

    Article  PubMed  Google Scholar 

  37. Meller J, Strutz F, Siefker J et al (2003) Early diagnosis and follow-up of aortitis with F-18 FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730–736

    Article  PubMed  CAS  Google Scholar 

  38. Webb M, Chambers A, Al-Nahhas A et al (2004) The role of F-18-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31:627–634

    Article  PubMed  Google Scholar 

  39. Hara M, Goodman PC, Leder RA (1999) FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23:16–18, Full Text via CrossRef

    Article  PubMed  CAS  Google Scholar 

  40. Dumarey N, Tang BN, Goldman S, Wautrecht JC, Matos C, Unger P, Nortier J (2007) Papillary muscle inflammation in Takayasu’s arteritis revealed by FDG–PET. Eur Heart J 28(8):1011

    Article  PubMed  Google Scholar 

  41. Blockmans D, Maes A, Stroobants S et al (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38:444–447

    Article  CAS  Google Scholar 

  42. Moosig F, Czech N, Mehl C et al (2004) Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63:870–873

    Article  PubMed  CAS  Google Scholar 

  43. Wildhagen K, Meyer GJ, Stoppe G, Heintz P, Deicher H, Hundeshagen H (1989) PET and MR imaging in a neuro-Behçet syndrome. Eur J Nucl Med 15(11):764–766

    Article  PubMed  CAS  Google Scholar 

  44. Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K, Nagata K (1989) Sequential PET studies in neuro-Behçet’s syndrome. J Neurol 236(6):367–370

    Article  PubMed  CAS  Google Scholar 

  45. Terada T (1991) Magnetic resonance imaging in neuro-Behçet’s disease—comparison with clinical, X-ray CT, and PET findings. Ryumachi 31(2):175–183

    PubMed  CAS  Google Scholar 

  46. Otte A, Weiner SM, Hoegerle S, Wolf R, Juengling FD, Peter HH, Nitzsche EU (1998) Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 7(1):57–59

    Article  PubMed  CAS  Google Scholar 

  47. Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377–385

    Article  PubMed  CAS  Google Scholar 

  48. Stoppe G, Wildhagen K, Meyer GJ, Schober O (1989) Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI. Nuklearmediziner 28(5):187–192

    CAS  Google Scholar 

  49. Meyer GJ, Schober O, Stoppe G, Wildhagen K, Seidel JW, Hundeshagen H (1989) Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods. Psychiatry Res 29(3):367–368

    Article  PubMed  CAS  Google Scholar 

  50. Wildhagen K, Stoppe G, Meyer GJ, Heintz P, Hundeshagen H, Deicher H (1989) Imaging diagnosis of central nervous system involvement in panarteritis nodosa. Z Rheumatol 48(6):323–325

    PubMed  CAS  Google Scholar 

  51. Park IN, Ryu JS, Shim TS (2008) Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 33(1):1–3

    Article  PubMed  CAS  Google Scholar 

  52. Chamilos G, Macapinlac HA, Kontoyiannis DP (2008) The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 46(1):23–29

    Article  PubMed  Google Scholar 

  53. Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92:2719–2724

    PubMed  CAS  Google Scholar 

  54. Bleeker-Rovers CP, Warris A, Drenth JP, Corstens FH, Oyen WJ, Kullberg BJ (2005) Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 11:493–495

    Article  PubMed  CAS  Google Scholar 

  55. Win Z, Todd J, Al-Nahhas A (2005) FDG–PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 30:690–691

    Article  PubMed  Google Scholar 

  56. Basu S, Asopa RV, Baghel NS (2009) Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG–PET. Clin Nucl Med 34(10):689–690

    Article  PubMed  Google Scholar 

  57. Jones HA, Marino PS, Shakur BS, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 21:567–573

    Article  PubMed  CAS  Google Scholar 

  58. Chen DL, Schuster DP (2004) Positron emission tomography with 18F-fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L834–L840

    Article  PubMed  CAS  Google Scholar 

  59. Jones HA, Clark JC, Minhas PS, Kendall IV, Downey SP, Menon DK (1998) Pulmonary neutrophil activation following head trauma. Am J Respir Crit Care Med 157:A349

    Google Scholar 

Download references

Conflict of Interest Statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Radiation Medicine Centre (BARC), Tata Memorial Hospital Annex, Parel, Bombay, 400012, India

    Sandip Basu

  2. Division of Nuclear Medicine, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA

    Babak Saboury, Tom Werner & Abass Alavi

Authors
  1. Sandip Basu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babak Saboury
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tom Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abass Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abass Alavi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basu, S., Saboury, B., Werner, T. et al. Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders. Mol Imaging Biol 13, 1051–1060 (2011). https://doi.org/10.1007/s11307-010-0459-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-010-0459-x

Key words

Search

Navigation